Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Opioid-Induced Respiratory Depression in Pediatric Palliative Care Patients with Severe Neurological Impairment—A Scoping Literature Review and Case Reports

Bibliographic Data

ID15717124
AuthorsMaximilian David Mauritz (0000-0002-9618-5307, German Center for Pediatric and Adolescent Rheumatology, corresponding author), Carola Hasan (Witten/Herdecke University), Larissa Alice Dreier (PedScience Research Institute, 45711 Datteln, Germany), Pia Schmidt (0000-0001-5843-8636, Witten/Herdecke University), Boris Zernikow (0000-0001-5875-3775, Witten/Herdecke University)
Year2020
Volume7
Issue12
Pages312-312
Publication date2020-12-21
Open AccessYes
TypeARTICLE
VenueChildren (JOURNAL)
Journal identifiersISSN: 2227-9067 • E-ISSN: 2227-9067
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/children7120312
PMID33371493
OpenAlexW3118026546
LanguageEN
References cited51

Pediatric Palliative Care (PPC) addresses children, adolescents, and young adults with a broad spectrum of underlying diseases. A substantial proportion of these patients have irreversible conditions accompanied by Severe Neurological Impairment (SNI). For the treatment of pain and dyspnea, strong opioids are widely used in PPC. Nonetheless, there is considerable uncertainty regarding the opioid-related side effects in pediatric patients with SNI, particularly concerning Opioid-Induced Respiratory Depression (OIRD). Research on pain and OIRD in pediatric patients with SNI is limited. Using scoping review methodology, we performed a systematic literature search for OIRD in pediatric patients with SNI. Out of n = 521 identified articles, n = 6 studies were included in the review. Most studies examined the effects of short-term intravenous opioid therapy. The incidence of OIRD varied between 0.13% and 4.6%; besides SNI, comorbidities, and polypharmacy were the most relevant risk factors. Additionally, three clinical cases of OIRD in PPC patients receiving oral or transdermal opioids are presented and discussed. The case reports indicate that the risk factors identified in the scoping review also apply to adolescents and young adults with SNI receiving low-dose oral or transdermal opioid therapy. However, the risk of OIRD should never be a barrier to adequate symptom relief. We recommend careful consideration and systematic observation of opioid therapy in this population of patients

Chronic pain · Depression (economics · Intensive care medicine · Opioid · Palliative care · Polypharmacy · Population · Psychiatry · SNi · Childhood Cancer Survivors' Quality of Life · Infant Development and Preterm Care · Medicine · Pediatric Pain Management Techniques · Internal Medicine · Pediatrics

  • Quantifying the Language Barrier—A Total Survey of Parents’ Spoken Languages and Local Language Skills as Perceived by Different Professions in Pediatric Palliative Care

    Open Access•Larissa Alice Dreier, Boris Zernikow et al.•Children•2020

Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae